Lavender Aromasticks for Pain Control

Patient Satisfaction Clinical Trial

Official title:

Lavender Aromasticks as an Option for Pain Control in the Vascular Surgery Population

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04396444
• Other study ID #: STUDY00011852
• Status: Completed
• Phase: N/A
• Start date: August 1, 2020
• Est. completion date: October 31, 2021

Study information

• Verified date: October 2022
• Source: Milton S. Hershey Medical Center
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this randomized pilot study is to collect preliminary data on the impacts of lavender essential oil aromatherapy on the patient-reported quality of pain management provided for the vascular surgery patient population. The investigators hypothesize that individuals who use a lavender aromastick as a part of their pain management plan will report improved perceptions of the quality of their pain management as measured by the Revised American Pain Society Patient Outcome Questionnaire (APS-POQ-R). Subjects will be randomized to the control (empty aromastick) and intervention group (aromastick infused with lavender oil), and will use this device as an addition to their pain management plan. Additionally, this pilot study will allow the researchers to evaluate the feasibility of a larger randomized control trial, assess the validity of the survey tool, and collect feedback from patients on the acceptability of the aromatherapy intervention as a complementary therapy during their hospital stay.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 6
• Est. completion date: October 31, 2021
• Est. primary completion date: October 31, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

1. Subjects 18 and over admitted to the vascular surgery service line on the Heart and Vascular Progressive Care Unit (HVPCU)

2. Not cognitively impaired

3. Able to perform teach-back of the education regarding safe use of the aromastick

4. Able to demonstrate use of the Numeric Pain Rating Scale (NPRS), as evidenced by their ability to answer the initial NPRS question on the Adult Admission II Form used to admit all patients to the hospital

5. English is the primary language, as identified by the Adult Admission II Form

Exclusion Criteria:

1. Subjects who are unable to consent themselves

2. Subjects who cannot provide teach-back on the safe use of the aromastick

3. Subjects unable to use the NPRS to rate their pain

4. Research team member and/or bedside nurse assess that subject has a cognitive deficit that would prohibit safe use of the aromastick

5. Subjects on suicide precautions

6. Pregnant subjects

7. Prisoners

8. Individuals under age 18

9. Subjects with a current plan to use personal aromatherapy devices during their inpatient stay

10. Subjects with known lavender allergy

Related Conditions & MeSH terms

• Pain Perception
• Patient Satisfaction

Intervention

Combination Product:
• Aromastick
Vascular surgery patients will be randomized to either the intervention group and receive a lavender infused aromastick to use as an adjunct to their inpatient pain management plan, or to the control group, given a blank aromastick. Subjects will be blinded to their group.

Locations

Country	Name	City	State
United States	Penn State Health Milton S. Hershey Medical Center	Hershey	Pennsylvania

Sponsors (2)

Lead Sponsor	Collaborator
Milton S. Hershey Medical Center	doTERRA International

Country where clinical trial is conducted

United States, 

References & Publications (1)

Gordon DB, Polomano RC, Pellino TA, Turk DC, McCracken LM, Sherwood G, Paice JA, Wallace MS, Strassels SA, Farrar JT. Revised American Pain Society Patient Outcome Questionnaire (APS-POQ-R) for quality improvement of pain management in hospitalized adults: preliminary psychometric evaluation. J Pain. 2010 Nov;11(11):1172-86. doi: 10.1016/j.jpain.2010.02.012. Epub 2010 Apr 18. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	The primary endpoints for this study are patients' self-reported evaluations of the quality of pain management provided during their hospital stay.	Measured using the Revised American Pain Society Patient Outcome Questionnaire (APS-POQ-R) survey tool. The APS-POQ-R has 18 primary questions with continuous rating scales from 0 - 10 or from 0% - 100%. This study, with permission from the original authors, uses a modified survey, with 10 questions evaluating the subject's pain levels and degree to which pain interferes with various aspects of their quality of life. In these questions, higher numbers indicate higher levels of pain and distress. Four additional Likert style questions evaluate subjects' satisfaction with pain management, with higher numbers indicating higher levels of satisfaction.	Measured on day 6 of hospital stay or day of discharge; whichever is sooner
Secondary	Subjects' evaluation of the aromastick	Survey questions will also be asked about use of the aromastick to evaluate acceptability of the intervention device. These are yes/no questions, and questions measuring the frequency of device use.	Measured on day 6 of hospital stay or day of discharge; whichever is sooner

External Links

•   Related Info